MedPath

Mecamylamine Hydrochloride

MECAMYLAMINE Hydrochloride Tablets, USP, 2.5 mg

Approved
Approval ID

1b79ef78-f4da-49a6-9f36-89b0da19d39b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 18, 2020

Manufacturers
FDA

LGM Pharma Solutions, LLC

DUNS: 117549198

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mecamylamine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code79739-7183
Application NumberANDA204054
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mecamylamine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateAugust 18, 2020
FDA Product Classification

INGREDIENTS (9)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Mecamylamine HydrochlorideActive
Quantity: 2.5 mg in 1 1
Code: 4956DJR58O
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TalcInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mecamylamine Hydrochloride - FDA Drug Approval Details